Protein crystallization strategies in structure-based drug design
Crystal structures will remain fundamental to structure-based drug design moving forward. Successful crystallization demands adaptable, multi-faceted strategies that systematically explore diverse protein variants and crystallization conditions. Future progress depends on integrating AI tools for construct design with project insights and robust experimental workflows. Success ultimately hinges on synergy between innovative problem-solving approaches and deep expertise in navigating this rapidly evolving landscape.
Authors
- Tove Sjögren (ORCID: https://orcid.org/0000-0002-6703-4200)
- Margareta Ek (ORCID: https://orcid.org/0000-0001-8226-8112)
- Linda Öster (ORCID: https://orcid.org/0000-0002-0344-2491)
- Helena Käck
Institutions
- AstraZeneca (Brazil) (BR)
Publication Details
- Journal
- Expert Opinion on Drug Discovery
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1080/17460441.2025.2605355
- Primary Topic
- Enzyme Structure and Function
- Type
- article
- Field-Weighted Citation Impact
- 0.00